Hudson Portfolio Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Hudson Portfolio Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$752K	Sell	3,121 -730	-19%	-$160K	0.57%	53
2026 Q1	$728K	Sell	3,851 -169	-4%	-$29.5K	0.61%	56
2025 Q4	$683K	Sell	4,020 -30	-0.7%	-$4.6K	0.59%	57
2025 Q3	$534K	Sell	4,050 -50	-1%	-$6K	0.47%	67
2025 Q2	$435K	Sell	4,100 -55	-1%	-$5.97K	0.41%	74
2025 Q1	$516K	Hold	4,155	–	–	0.5%	65
2024 Q4	$512K	Sell	4,155 -98	-2%	-$11.6K	0.5%	64
2024 Q3	$474K	Buy	+4,253	New	+$466K	0.47%	70
2023 Q4	$213K	Sell	1,733 -40	-2%	-$4.99K	0.23%	94
2023 Q3	$229K	Hold	1,773	–	–	0.26%	88
2023 Q2	$220K	Hold	1,773	–	–	0.24%	96
2023 Q1	$259K	Hold	1,773	–	–	0.29%	89
2022 Q4	$282K	Hold	1,773	–	–	0.31%	84
2022 Q3	$236K	Hold	1,773	–	–	0.28%	88
2022 Q2	$277K	Sell	1,773 -12	-0.7%	-$1.85K	0.29%	82
2022 Q1	$278K	Hold	1,785	–	–	0.25%	95
2021 Q4	$227K	Hold	1,785	–	–	0.2%	99
2021 Q3	$232K	Hold	1,785	–	–	0.21%	92
2021 Q2	$317K	Buy	+1,785	New	+$309K	0.29%	86

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Hudson Portfolio Management's JAZZ Position: Q2 2026 in Review

Hudson Portfolio Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 19% in Q2 2026, selling an estimated $160K and leaving 3,121 shares worth $752K. The position accounts for 0.57% of the portfolio, ranked #53.

Hudson Portfolio Management first reported a position in JAZZ in Q2 2021 and has held it in 19 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Hudson Portfolio Management held 3,121 shares of Jazz Pharmaceuticals worth $752K as of Q2 2026.
Hudson Portfolio Management sold 730 Jazz Pharmaceuticals shares in Q2 2026, an estimated $160K.
Jazz Pharmaceuticals made up 0.57% of Hudson Portfolio Management's portfolio in Q2 2026, its #53 holding.
Hudson Portfolio Management first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 19 quarters since.
647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Hudson Portfolio Management's 13F filing for Q2 2026, filed 12 Aug 2026.